What is the ticker symbol for INmune Bio?

INmune Bio trades under the ticker INMB on NASDAQ.

What sector does INmune Bio operate in?

INmune Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze INMB in a portfolio?

PortView shows INMB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

INmune Bio (INMB) Stock Analysis

NASDAQHealthcareBiotechnology

$2.25+0.22%

1-year price historyRange $1.12 – $2.44

52-week range$2.25

$1.09$2.50

What INmune Bio does

INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies. Its primary objective is to harness the body's innate immune system to combat various illnesses. The company is actively engaged in developing and bringing to market therapeutic candidates designed to address a spectrum of conditions such as blood cancers, solid tumors, and chronic inflammatory diseases. Its pipeline features key development programs including: INKmune: Aimed at treating women suffering from relapsed or refractory ovarian carcinoma and individuals diagnosed with high-risk myelodysplastic syndrome. INB03: An immunotherapy targeting patients with both hematologic malignancies and solid tumors. XPro1595: Under development for the treatment of Alzheimer's disease. INmune Bio holds licensing agreements with entities including Xencor, Inc., Immune Ventures, LLC, the University of Pittsburgh, and University College London. Established in 2015, INmune Bio is headquartered in Boca Raton, Florida.

Key metrics

Market cap

$59.68M

P/E (TTM)

-3.35

EPS (TTM)

$-0.67

Beta

0.90

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.93

200-day avg

$1.59

52-week high

$2.50

52-week low

$1.09

CEO

David J. Moss

ETFs linked to INMB

Broad-market and Healthcare sector ETFs an investor holding INmune Bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how INMB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze INMB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for INmune Bio?: INmune Bio trades under the ticker INMB on NASDAQ.
Which exchange is INMB listed on?: INMB is listed on NASDAQ.
What sector does INmune Bio operate in?: INmune Bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze INMB in a portfolio?: PortView shows INMB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.